Back
Special Edition : PAR and IXC Update
An update on two of our larger holdings, Paradigm Biopharmaceuticals and Invex Therapeutics. Have had a lot of requests for this, so hope you enjoy it.
The FiftyOne Capital Podcast is a series of audio updates on global markets, how the fund is positioned, or any variety of topics we feel could be of benefit to our investors. If you wish to contact us, visit our website at www.fiftyonecapital.com or contact us on investor@fiftyonecapital.com The information in this podcast is strictly general in nature and is not advice or based on your personal situation. Do your own research.
Play:
19 min and 52 sec